4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Shattuck Labs, Inc. (STTK) operates in the Biotechnology industry and is headquartered in Austin, United States with about 40 employees. Its market capitalization is roughly $671 million. In the fiscal year ended 2025-12-31, STTK reported $1M in revenue and ($49M) in net income.
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States.
Interactive charts & full statements → Open the STTK valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $1M | $6M | $2M | $1M |
| Operating Income (EBIT) | ($52M) | ($81M) | ($92M) | ($103M) |
| Net Income | ($49M) | ($75M) | ($87M) | ($102M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $1M | $0M | $0M |
| Operating Income (EBIT) | ($16M) | ($13M) | ($11M) | ($13M) | ($14M) |
| Net Income | ($15M) | ($13M) | ($10M) | ($12M) | ($14M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $91M | $91M | $160M | $205M | — |
| Total Liabilities | $9M | $11M | $15M | $29M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive STTK viewer.
About TickerBase · Data methodology & sources